C4 Therapeutics
NASDAQ: CCCCCambridge, US · Founded 2015 · Delaware corporation · 4 known investors
C4 Therapeutics develops targeted protein degradation medicines aimed at treating disease. The company works in the biotechnology and drug development space.
Founders & leadership
Board
MC
Marc CohenBoard director
JF
Jason FishermanBoard director
MS
Miles StuchinBoard director
BD
Bruce DowneyBoard director
BC
Bihua ChenBoard director
WM
William M. ScalzulliBoard director
KA
Kenneth AndersonBoard director
MS
Malcolm S. SalterBoard director
JE
Jay EastmanBoard director
AC
Alain CohenBoard director
EP
Elena ProkupetsBoard director
RW
Ronald W. KaiserBoard director
Investors · 4
Reported raises · per SEC filings
Form D private placements$70.3M disclosed across 1 round · 2015
▶$70.3MraisedJan 2016 · 55 investors · BiotechnologyRule 506(b)
▶$70.3MraisedJan 2016 · 55 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Marc CohenExecutive Officer, Director
- Jason FishermanExecutive Officer, Director
- Miles StuchinDirector
- William M. ScalzulliDirector
- Kenneth AndersonDirector
- Malcolm S. SalterDirector
- Bruce DowneyDirector
- Jay EastmanDirector
- Alain CohenDirector
- Elena ProkupetsDirector
- Bihua ChenDirector
- Ronald W. KaiserDirector
- Offering amount
- $73.5M
- Amount sold
- $70.3M
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapKite Pharma84 shared keywordsKite Pharma develops CAR T-cell therapies for cancer patients, engineering the immune system's cells to target and attack cancer. Each therapy is individualized per patient through a multi-step manufacturing process.
Robinhood53 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Companies competing with C4 Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does C4 Therapeutics do?
- C4 Therapeutics develops targeted protein degradation medicines aimed at treating disease. The company works in the biotechnology and drug development space.
- Who are C4 Therapeutics's investors?
- C4 Therapeutics's investors include 3E Bioventures Capital, Bain Capital Life Sciences, Nextech Invest, RA Capital.
- How much funding has C4 Therapeutics raised?
- C4 Therapeutics has disclosed $70.3M raised across 1 round.
- Where is C4 Therapeutics headquartered?
- C4 Therapeutics is headquartered in Cambridge, US.